Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06088277 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv8
  2. Notable Primary and study completion dates: Sep 2026 to Apr 14, 2027v7
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Aug 2024 to Aug 16, 2024
    v6
  4. Minor Start date: Jul 2024 to Aug 2024v5
  5. Notable Start date: May 2024 to Jul 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Mar 2024 to May 2024v3
  2. Notable Start date: Dec 2023 to Mar 2024v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
Trial Details
NCT Number NCT06088277
Lead Sponsor Boston University
Collaborators: National Institute of Dental and Craniofacial Research (NIDCR)
Conditions
(from sponsor)
HIV Infections
Related terms HIV Infections
Enrollment 266 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov